IMF Videos Search Content For Care Partner (360) Patient (356) Healthcare Provider (216) Healthcare Professional (213) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (22) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (34) Myeloma in a Minute (26) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (22) Recent News and Developments (7) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (188) Financial Considerations (15) Frontline Therapy (84) Health Equity (35) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (73) Lifestyle (48) Mental & Emotional Health (30) Myeloma 101 (61) Myeloma in the News (9) Public Policy & Advocacy (17) Q&A's (44) Recorded Seminars & Workshops (15) Recorded Webinars (25) Relapse/Refractory Myeloma (139) Research Updates (196) Symptom Management (117) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (151) High-Risk Myeloma (98) High-risk Smoldering Myeloma (72) Late Relapse (4–6 Lines of Therapy) (162) MGUS (89) Newly Diagnosed (Pre-Treatment or First Treatment) (160) Smoldering Myeloma (112) Types of Therapy Immunomodulatory drugs (IMiDs) (96) Immunotherapies (CAR T; BiTE, etc.) (163) Monoclonal antibodies (80) Proteasome inhibitors (67) Stem cell transplant (85) Steroids (64) Supportive Care (154) Year Published 2026 (53) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (109) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (30) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Urvi A. Shah (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance What are CRAB and pre-CRAB criteria in myeloma diagnosis, and how do they affect treatment decision-making? April 16, 2024 Ask Dr. Durie How valuable is minimal residual disease testing for myeloma patients? April 11, 2024 Ask Dr. Durie Ask Me Anything Replay: Insights from Dr. Urvi A. Shah, Memorial Sloan Kettering April 4, 2024 Facebook Live What concerns about the early use of CAR-T therapy were addressed in the ODAC hearing? April 4, 2024 Ask Dr. Durie Living Well With Myeloma: Medicare March 27, 2024 Living Well with Myeloma Ask Me Anything Replay: Insights from IMF NLB Member Beth Faiman March 27, 2024 Facebook Live Ask Me Anything Replay: Dr. Mikhael and Dr. Kaur Discuss Myeloma Live March 27, 2024 Facebook Live What are considerations for myeloma patients regarding immune therapy targets, side effects, and monitoring? March 21, 2024 Ask Dr. Durie IMF Patient and Family Seminar 2024 — Boca Raton, FL March 15, 2024 Patient & Family Webinar What are early insights from iStopMM regarding preventing myeloma progression? March 14, 2024 Ask Dr. Durie What is the significance of mass spectrometry in measuring myeloma protein levels? March 7, 2024 Ask Dr. Durie Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma February 22, 2024 ASH Load More
